A patient at the University of Alabama at Birmingham (UAB) became the first person in America to undergo an investigational therapy for emphysema that uses a foam sealant sprayed into the lungs.

On Oct. 29, 2012, Perry Waldrop, 55, of Cullman, Ala., was treated in a late-stage clinical trial of the AeriSeal System. The therapy, approved for use in parts of Europe and Israel, is undergoing investigation in the United States as a potential method of reducing lung volume in patients with severe emphysema.

Read story here: bit.ly/VwnUlg

# vimeo.com/60091853 Uploaded 702 Plays / / 0 Comments Watch in Couch Mode

Follow

Research

uabnews Plus

UAB, home to some of the nation’s most prestigious centers for the study of cancer, neuroscience, AIDS, diabetes and more, excels at translating medical discoveries in the lab to revolutionary therapies at the bedside and in clinics.

Shout Box

Browse This Channel

Channels are a simple, beautiful way to showcase and watch videos. Browse more Channels. Channels